Since their discovery, therapeutic or prophylactic vaccines represent a promising option to prevent or cure infections and other pathologies, such as cancer or autoimmune disorders. More recently, among a number of nanomaterials, gold nanoparticles (AuNPs) have emerged as novel tools for vaccine developments, thanks to their inherent ability to tune and upregulate immune response. Moreover, owing to their features, AuNPs can exert optimal actions both as delivery systems and as adjuvants. Notwithstanding the potential huge impact in vaccinology, some challenges remain before AuNPs in vaccine formulations can be translated into the clinic. The current review provides an updated overview of the most recent and effective application of gold nanoparticles as efficient means to develop a new generation of vaccine.
Gold nanoparticle-based platforms for vaccine development / R.M. Ferrando, L. Lay, L. Polito. - In: DRUG DISCOVERY TODAY: TECHNOLOGIES. - ISSN 1740-6749. - 38:(2020 Dec), pp. 57-67. [10.1016/j.ddtec.2021.02.001]
Gold nanoparticle-based platforms for vaccine development
L. Lay
Penultimo
;
2020
Abstract
Since their discovery, therapeutic or prophylactic vaccines represent a promising option to prevent or cure infections and other pathologies, such as cancer or autoimmune disorders. More recently, among a number of nanomaterials, gold nanoparticles (AuNPs) have emerged as novel tools for vaccine developments, thanks to their inherent ability to tune and upregulate immune response. Moreover, owing to their features, AuNPs can exert optimal actions both as delivery systems and as adjuvants. Notwithstanding the potential huge impact in vaccinology, some challenges remain before AuNPs in vaccine formulations can be translated into the clinic. The current review provides an updated overview of the most recent and effective application of gold nanoparticles as efficient means to develop a new generation of vaccine.File | Dimensione | Formato | |
---|---|---|---|
DrugDiscoveryToday_2021_in press.pdf
accesso aperto
Descrizione: Online first
Tipologia:
Publisher's version/PDF
Dimensione
726.61 kB
Formato
Adobe PDF
|
726.61 kB | Adobe PDF | Visualizza/Apri |
1-s2.0-S1740674921000032-main.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
821.82 kB
Formato
Adobe PDF
|
821.82 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.